T1	Participants 166 205	retinal angiomatous proliferation (RAP)
T2	Participants 33 66	retinal angiomatous proliferation
T3	Participants 355 421	Thirty-four patients with RAP with any stage of neovascularization
T4	Participants 1460 1477	patients with RAP
